A kind of pharmaceutical composition for treating obese polycystic ovary syndrome
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of polycystic ovary and composition, which is applied in the field of pharmaceutical composition for the treatment of obese polycystic ovary syndrome, and can solve problems such as side effects and poor therapeutic effect
Inactive Publication Date: 2021-06-08
THE AFFILIATED HOSPITAL OF SHANDONG UNIV OF TCM
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, the above drugs are ineffective and have certain side effects, and patients with polycystic ovary syndrome usually need a relatively long-term medication treatment process, so it is particularly urgent to seek safe and effective drugs for the treatment of polycystic ovary syndrome
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0032] Recipe: 6 grams of ginger pinellia, 30 grams of fairy spleen, 10 grams of atractylodes, 20 grams of poria cocos, 12 grams of tangerine peel, 30 grams of Dipsacus, 10 grams of Cyperus cyperi, 20 grams of salvia miltiorrhiza, 10 grams of Achyranthes bidentata, 10 grams of plantago seed, cinnamon 6 grams, Zhi Licorice 6 grams.
[0033] Preparation:
[0034] Mix ginger pinellia, xianlingpi, atractylodes atractylodes, Poria cocos, tangerine peel, Dipsacus cyperi, Cyperus cyperi, Salvia miltiorrhiza, Achyranthes bidentata, plantain seed, cinnamon and roasted licorice, add water to decoct twice, filter (the first time add 7-10 Double the amount of water, decoct for 30 minutes; add 5-8 times the amount of water for the second time, decoct for 20 minutes), combine the filtrates, and get ready.
[0035] The decocted filtrate is taken orally, twice a day in the morning and evening, and three menstrual cycles are a course of treatment.
Embodiment 2
[0037]Recipe: 4 grams of ginger pinellia, 35 grams of fairy spleen, 8 grams of atractylodes, 24 grams of Poria, 10 grams of tangerine peel, 35 grams of Dipsacus, 8 grams of Rhizoma Cyperus, 24 grams of Salvia, 8 grams of Achyranthes bidentata, 12 grams of plantago, cinnamon 4 grams, Zhi Licorice 8 grams.
[0038] The preparation method of the pharmaceutical composition is the same as in Example 1, and then prepared into capsules in a conventional manner.
Embodiment 3
[0040] Recipe: 8 grams of ginger pinellia, 25 grams of fairy spleen, 12 grams of atractylodes, 16 grams of poria cocos, 14 grams of dried tangerine peel, 25 grams of Dipsacus, 12 grams of Cyperus cyperi, 16 grams of salvia miltiorrhiza, 12 grams of Achyranthes bidentata, 8 grams of plantago seed, cinnamon 8 grams, Zhi Licorice 4 grams.
[0041] The preparation method of the pharmaceutical composition is the same as in Example 1, and then prepared into pills in a conventional manner.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a pharmaceutical composition for treating obese polycystic ovary syndrome. The raw materials are composed of 4-8 parts of ginger pinellia, 25-35 parts of fairy spleen, 8-12 parts of atractylodes rhizome, 16-24 parts of poria cocos, 10-14 parts of tangerine peel, 25-35 parts of Dipsacus, 8-12 parts of Cyperus cyperi, 16-24 parts of Salvia miltiorrhiza, 8-12 parts of Achyranthes knuckles, 8-12 parts of plantain seed, 4-8 parts of cinnamon, 4 parts of roasted licorice ‑8 servings. The medicinal materials selected for the pharmaceutical composition of the present invention are compatible, the prescriptions are refined, and the functions complement each other. The purpose is to promote dampness and eliminate phlegm, and it integrates expectorant, warming kidney, promoting qi, invigorating the spleen, promoting blood circulation, and tonifying. Significant; in terms of medicinal properties, they are compatible with each other, with less toxic and side effects.
Description
technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating obese polycystic ovary syndrome. Background technique [0002] Polycystic ovary syndrome (PCOS) is a common gynecological endocrine metabolic disease characterized by long-term anovulation and androgen excess. It is a syndrome with multiple pathogenesis and diverse clinical manifestations. The prevalence rate is as high as 5-12% in women of childbearing age, and its main clinical manifestations are menstrual disorders, infertility, obesity, hirsutism, acne, etc., which not only increase the risk of gestational diabetes and pregnancy-induced hypertension, but also increase the risk of endometrial hyperplasia. Cancer, diabetes, atherosclerosis, coronary heart disease and other long-term metabolic diseases have a serious impact on women's quality of life. Long-term anovulation brings harm to women's physical and mental ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more